Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 391 AL 405

Adaptive immunity in the neuroinflammation of Alzheimer's disease

Liu H, Chen Y, Zhang J, Chen X.

Chin Med J (Engl). 2025 Sep 5;138(17):2116-2129. doi: 10.1097/CM9.0000000000003695. Epub 2025 Aug 5.

Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease

Nelson VK, Begum MY, Dera AA, Ali SP, Suryadevara PR.

Eur J Pharmacol. 2025 Oct 15;1005:178034. doi: 10.1016/j.ejphar.2025.178034. Epub 2025 Aug 5.

Management of sleep disturbance related to Alzheimer disease and dementia: An updated review of ClinicalTrials.gov

Aldurdunji MM.

Medicine (Baltimore). 2025 Aug 8;104(32):e43725. doi: 10.1097/MD.0000000000043725.

From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease

Jiang F, Wang N, Meng Q.

J Alzheimers Dis. 2025 Sep;107(2):421-438. doi: 10.1177/13872877251360321. Epub 2025 Sep 1.

Clusterin Regulates the Mechanisms of Neuroinflammation and Neuronal Circuit Impairment in Alzheimer's Disease

Yu Y, Wang C, Wang B, Wang X, Zhao Q, Yan Y, Liu X.

Int J Mol Sci. 2025 Jul 28;26(15):7271. doi: 10.3390/ijms26157271.

Understanding the role of microglia in Alzheimer's disease: insights into mechanisms, acupuncture, and potential therapeutic targets

Jinglei J, Tao YU, Yulin Q, Meng W.

J Tradit Chin Med. 2025 Aug;45(4):922-936. doi: 10.19852/j.cnki.jtcm.20250327.002.

Rationale and emerging evidence for microglial replacement in Alzheimer's disease

Bang JY, Yoo Y.

Mol Cells. 2025 Oct;48(10):100265. doi: 10.1016/j.mocell.2025.100265. Epub 2025 Aug 14.

PANoptosis: Potential Therapeutic Prospects in Alzheimer's Disease

Guo Z, Wan Y.

Eur J Neurosci. 2025 Aug;62(4):e70231. doi: 10.1111/ejn.70231.

Beyond Neuroinflammation: Microglia at the Crossroads of Amyloid, Tau, and Neurodegeneration in Alzheimer's Disease

Ebrahimi R, Bordbar S, Azad G, Davoody S, Mahmoudi M, Esmaeilpour K.

Neurol Sci. 2025 Nov;46(11):5591-5605. doi: 10.1007/s10072-025-08403-4. Epub 2025 Aug 19.

The Crosstalk Between Protective and Detrimental Interleukin (IL)-1 Family of Cytokines in Alzheimer's Disease

Liu T, Li X.

J Biochem Mol Toxicol. 2025 Sep;39(9):e70460. doi: 10.1002/jbt.70460.

The emerging role of disulfidptosis in Alzheimer's disease

Zhou Q, Zheng N, Chen Z, Xie L, Yang X, Sun Q, Lin J, Li B, Li L.

Eur J Pharmacol. 2025 Oct 15;1005:178085. doi: 10.1016/j.ejphar.2025.178085. Epub 2025 Aug 21.

Tau and Amyloid beta causes microglial activation in Alzheimer's disease

Chinnathambi S, Adithyan A, Chandrashekar M, Rangappa N.

Adv Clin Chem. 2025;128:83-107. doi: 10.1016/bs.acc.2025.06.002. Epub 2025 Jul 11.

Copper homeostasis and cuproptosis in Alzheimer's disease (Review)

Cong C, Cong H, Yao Y, Bai Y, Xu L.

Int J Mol Med. 2025 Nov;56(5):172. doi: 10.3892/ijmm.2025.5613. Epub 2025 Aug 24.

Cell-specific copper dyshomeostasis mechanism in Alzheimer's disease

Okafor M, Faller P, Vitale N.

Transl Neurodegener. 2025 Aug 22;14(1):42. doi: 10.1186/s40035-025-00504-6.

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review

de Rijke TJ, Engelsma T, Ng CH, Kaijser KK, Nap HH, Smets EM, Visser LN.

J Med Internet Res. 2025 Aug 25;27:e64862. doi: 10.2196/64862.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias